$218 Billion is the total value of 72 Investment Holdings, LLC's 5 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | PROMETHEUS BIOSCIENCES INC | $203,282,640 | +186308.9% | 1,848,024 | 0.0% | 93.46% | +8.2% | |
| ENTRADA THERAPEUTICS INC | $6,881,991 | +85689.0% | 509,023 | 0.0% | 3.16% | -50.2% | ||
| CARIBOU BIOSCIENCES INC | $2,977,141 | +59430.9% | 474,067 | 0.0% | 1.37% | -65.4% | ||
| PRAX | PRAXIS PRECISION MEDICINES I | $2,353,808 | +104746.7% | 988,995 | 0.0% | 1.08% | -39.1% | |
| OMEGA THERAPEUTICS INC | $2,015,293 | +105247.3% | 352,941 | 0.0% | 0.93% | -38.8% |
Signatures
The EDGAR filing(s) were signed by:
- Jason M. Colombo — Authorized Person
- 72 Investment Holdings, LLC holdings (13F-HR)
- 72 Investment Holdings, LLC ownership history
- 72 Investment Holdings, LLC portfolio value
- 72 Investment Holdings, LLC insiders transactions
- 72 Investment Holdings, LLC filings
- Similar filers BETA
Compare quarterly holdings
Export 72 Investment Holdings, LLC's holdings